搜尋結果
Alzheimer's drug from Eisai and Biogen rejected in Europe
Reuters· 18 小時前... for early Alzheimer's disease, saying the risk of serious brain swelling</ ... ...
Amazon’s Swelling Cash Pile Makes Conditions Ripe for Dividend
Bloomberg· 2 日前With a cash hoard that’s expected to top $100 billion this year, conditions have never been ...
Typhoon Gaemi hits Chinese seaboard, widespread flooding feared
Reuters· 2 日前Typhoon Gaemi roared into southeastern China on Thursday after churning across the Taiwan ...
What To Know About The Deadly Nipah Virus As India Races To Contain Another Outbreak
Forbes· 5 日前Health officials in India are racing to contain an outbreak of Nipah virus after a teenage boy ...
India is on alert after a fresh outbreak of the deadly Nipah virus. Here’s what you need to know
CNBC· 2 日前Bats are believed to be one of the carriers of Nipah virus, a zoonotic disease that spreads ...
Council Post: How To Navigate The Cloud’s Newest Spending Problem: GenAI
Forbes· 2 日前For years, innovation has spurred glutenous cloud spending, but it’s now swelling to new peaks ...
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
CNBC· 1 日前European drug regulators on Friday rejected the Alzheimer's treatment Leqembi from Biogen ...
One dead from Nipah virus in India's Kerala state, state health minister says - English ...
metroradio.com.hk· 6 日前Authorities in southern India's Kerala state are taking preventive steps after the death of a 14-year-old boy from the Nipah ...
Leveraged Nvidia ETFs ramp up investor risk as tech turbulence hits markets
Reuters· 2 日前s tech-led selloff continues. Exchange-traded funds (ETFs) designed to magnify the daily moves ...
How To Make A Mattress More Comfortable Using 6 Easy Tricks
Forbes· 2 日前Sleep is essential to your overall health and well-being, but that can be hard to come by when ...